Luís Rodrigues

Dr. Luís Rodrigues

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in GE - Portuguese Journal of Gastroenterology
Verified
Journal Article
Open access
PDF file
LRLuís Rodrigues
Luís Rodrigues
SASofia Almeida
Sofia Almeida
CSCatarina Salgado
Catarina Salgado
CGCristina Campos Gonçalves
Cristina Campos Gonçalves
Introduction: Sickle cell intrahepatic cholestasis (SCIC) is one of the rarest and the most severe acute hepatic manifestations of sickle cell disease (SCD) and it can rapidly progress to acute liver failure. It is associated with a high mortality rate, demanding prompt recognition and management. Case Presentation: We report a case of a 7-year-old boy with a history of homozygous HbS SCD who presented to the emergency department with fever, increasing abdominal pain, and jaundice. His course was complicated by acute liver injury (AST 9,472 IU/L, ALT 2,683 IU/L, total bilirubin 15.4 mg/dL; conjugated bilirubin 8.69 mg/dL, hypoalbuminemia 2.6 g/dL, and persistent hypoglycemia), with acute liver failure (coagulopathy not corrected by vitamin K administration with INR 3.26, decreased factors V 10% and VII 28%, and West Haven grade I hepatic encephalopathy associated with mild hyperammonemia of 71 µmol/L). After excluding other causes of acute liver failure, the patient was diagnosed as having SCIC and was successfully treated with manual exchange transfusion. Conclusion: This case reinforces that exchange transfusion is an effective treatment for SCIC and that it should be introduced promptly to prevent fulminant and potentially fatal liver failure.

13 February 2026 in Children
Verified
Journal Article
Open access
PDF file
GCGuilherme Dias Cabaço
Guilherme Dias Cabaço
LRLuís Rodrigues
Luís Rodrigues
Background: Pediatric inflammatory bowel disease (IBD) is characterized by a heterogeneous and often aggressive disease course, requiring complex multimodal assessment and long-term monitoring. Artificial intelligence (AI) has emerged as a promising tool to support clinical decision-making by enabling an objective analysis of large, multidimensional datasets. Objectives: This narrative review aims to critically synthesize current evidence on the application of AI across the diagnosis, monitoring, and treatment of pediatric IBD. Methods: A narrative literature review was conducted using the PubMed (MEDLINE) and Cochrane Library databases, including publications available up to December 2025. Pediatric-focused studies were prioritized. However, due to the limited availability of pediatric-specific AI research, a considerable proportion of the evidence reviewed derives from adult or mixed cohorts, which were included when methodological frameworks or clinically relevant endpoints were applicable to pediatric IBD. Eligible publications included narrative and systematic reviews, observational studies, and clinical trials focusing on AI applications in endoscopy, histology, imaging, disease monitoring, and therapeutic response prediction. Results: AI-based models, particularly those using machine learning and deep learning, demonstrated promising performance in the automated analysis of endoscopic, histological, and imaging data, reducing interobserver variability and improving workflow efficiency. Multimodal approaches integrating imaging, clinical, and biomarker data consistently outperformed unimodal models. Emerging applications in patient-centered monitoring, digital biomarkers, and telemedicine enabled continuous disease assessment and early detection of flares, with particular relevance in pediatric settings where repeated, non-invasive monitoring is essential. AI-driven models also showed promising accuracy in predicting therapeutic response, supporting treatment stratification and precision medicine strategies. Conclusions: AI shows promising potential to complement clinical expertise in pediatric IBD by supporting diagnostic assessment, disease monitoring, and therapeutic optimization. However, translation into routine clinical practice remains constrained by methodological heterogeneity, limited pediatric-specific validation, and unresolved ethical and regulatory challenges. Future research should prioritize prospective multicenter pediatric studies, the development of transparent and explainable models, and the integration of AI-based tools into clinically meaningful and patient-centered care pathways.

16 July 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
SASara Valério de Azevedo
Sara Valério de Azevedo
LRLuís Rodrigues
Luís Rodrigues
Ana Isabel LopesAna Isabel Lopes
Ana Isabel Lopes
Background: Pediatric Crohn’s Disease (CD) affects more than physical health, influencing emotional well-being, social integration, and developmental milestones, with an impact on disease management. This study aimed to explore adolescents’ lived experiences with CD and identify factors influencing their motivation for self-management. Methods: A descriptive, cross-sectional qualitative study was conducted using a semi-structured, self-administered online questionnaire. Participants (n = 10) were adolescents with CD who had been diagnosed for over three years and were recruited from a tertiary pediatric gastroenterology center. Data included demographics, clinical characteristics, IMPACT-III (HRQOL), and PROMIS short forms. Open-ended responses underwent thematic analysis using the framework developed by Braun and Clarke. Results: Participants (80% female, median age 16.2 years, median disease duration 4.6 years) were all in clinical remission (median PCDAI = 2) and with good quality of life (median IMPACT-III = 80.7). Six themes emerged: (1) disease knowledge, (2) emotional responses, (3) coping and adaptation, (4) social support, (5) daily life and school impact, and (6) transition to adult care. Most participants demonstrated strong disease literacy and reported effective coping strategies. Emotional responses to diagnosis ranged from relief (60%) to distress (40%); relapses commonly triggered anxiety and fear. Therapeutic changes and disease monitoring were perceived as beneficial (100%) but with concern. Diagnostic procedures were viewed as burdensome by 70% of respondents. School performance and extracurricular participation were negatively affected in 40% during flares. Concerns regarding the future were reported by 40% of participants, with 30% believing that CD might limit life aspirations. While 60% managed their disease independently, 30% relied on parental support. All acknowledged the need for transition to adult care, though readiness varied. Conclusions: This study illustrates the overall impact of disease on pediatric CD patients. It reports significant emotional challenges and difficulties, as well as an impact on daily life, despite good disease knowledge. The findings underscore the importance of psychosocial well-being, ongoing mental health assessment, non-invasive monitoring, and holistic care, emphasizing the patient perspective, in managing pediatric CD.

22 November 2024 in GE - Portuguese Journal of Gastroenterology
Verified
Journal Article
Open access
IRInês Rodrigues
Inês Rodrigues
LRLuís Rodrigues
Luís Rodrigues
ALAna I. Lopes
Ana I. Lopes
LCLuís Correia
Luís Correia
MMMiguel Moura
Miguel Moura
Introduction: Achalasia is a rare disorder, with few cases occurring during childhood. It is also part of the Allgrove syndrome phenotype and a clinical feature that has a major impact on children’s development. Timely diagnosis and effective treatment of symptoms are essential. The novel peroral endoscopic myotomy (POEM) may represent an effective alternative in children. Case Presentation: We present the case of a female child born in 2013, without relevant family history or perinatal events. At six years old she presented with seizures related to recurrent hypoglycemia episodes and adrenal insufficiency was diagnosed. Two years later, the patient was referred to our institution due to regurgitation and vomiting, causing failure to thrive. After an upper endoscopy with no significant findings, high-resolution manometry revealed type II achalasia. Alacrimia was also part of the clinical picture and Allgrove syndrome was genetically confirmed. Due to significant symptoms, an endoscopic pneumatic dilation was performed, with transient relief of symptoms. After a second pneumatic dilation and several hospitalizations due to achalasia complications, a POEM was considered. She underwent POEM in March 2024, without adverse events and excellent short term outcomes. Discussion: Although there is limited literature on POEM in children, the results demonstrate an encouraging success rate, compared to pneumatic dilation and laparoscopic Heller’s miotomy. We present the first reported case of POEM performed in a child in Portugal. The long-term efficacy of this promising minimally invasive procedure should be assessed in the pediatric population.

1 July 2020 in Acta Medica Portuguesa
Verified
Journal Article
Open access
PDF file
LRLuís Rodrigues
Luís Rodrigues
RDRui Domingues
Rui Domingues
DADiana Amaral
Diana Amaral
JCJosé Cavaco
José Cavaco
Os tumores pulmonares primários em idade pediátrica são raros, existindo, contudo, uma multiplicidade de tipos histológicos, com diferentes abordagens terapêuticas. O tumor miofibroblástico inflamatório do pulmão representa 0,04% - 1,2% de todos os tumores pulmonares, é mais frequente em crianças e adultos jovens e a sua etiologia é desconhecida. A apresentação clínica e radiológica é muito variável, pelo que o diagnóstico é difícil. Descrevemos o caso de um adolescente de 15 anos, com achado de nódulo pulmonar em radiografia de tórax realizada no contexto de infeção respiratória e cujo estudo etiológico revelou tratar-se de um tumor miofibroblástico inflamatório do pulmão. Foi realizada resseção atípica por toracoscopia videoassistida, verificando-se evolução favorável. Salientamos a raridade desta entidade, a necessidade de elevado índice de suspeição clínica e a marcha diagnóstica que levou ao esclarecimento definitivo e à sua resolução.

8 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SASara Valério de Azevedo
Sara Valério de Azevedo
LRLuís Rodrigues
Luís Rodrigues
Ana Isabel LopesAna Isabel Lopes
Ana Isabel Lopes
Introduction and objectives: Pediatric inflammatory Bowel Disease (IBD) patients often face challenges in coping and disease management, which can impact self-management. This study investigates these patients' conceptualization of the disease and motivations for self-management. Methods: Descriptive cross-sectional study using a self-administered, semi-structured online questionnaire applied to pediatric Crohn’s Disease (CD) patients diagnosed>3 years, aiming to assess the impact of living with CD. Results: 10 patients included, 80% female, mean age 15.4 years, mean disease duration of 5.2 years. All patients were in remission with mean PCDAI of 3 (±4.8) and a mean IMPACT III score of 81.1). All patients reported good disease knowledge and adequate coping. Emotional responses at diagnosis included relief (60%) and negative emotions (40%). During relapses, anxiety and fear were prevalent, with 40% struggling with relapses. Therapeutic changes and monitoring were viewed as beneficial (100%) but with concern; 70% found monitoring tests a negative experience. Daily life impact was reported by 20%, with school accomplishments affected during relapses (40%). Extracurricular activities were limited during active disease (40%). Concerns about the future were noted by 40%, with 30% believing CD might limit their future. Most patients described appropriate self-efficacy: 60% self-managed, while 30% relied on parents. Transition to adult care was deemed necessary. Conclusion: This study illustrates the overall impact of disease on pediatric CD patients. It reports significant emotional and daily life challenges. The findings underscore the importance of psychosocial well-being, ongoing mental health assessment, non-invasive monitoring, and holistic care, emphasizing the patient perspective in managing pediatric CD.